Felipe Guapo, Ph.D.

Felipe holds a Ph.D. in Biology from Maynooth University, Ireland. His project focused on the development of proteomics approaches for the characterization of biomarkers of toxicological exposure. He joined CCL in 2020 as a postdoctoral researcher, working as part of a project funded by Enterprise Ireland in partnership with Pharmaron-UK. The project aimed to develop novel analytical techniques for the purification and characterization of AAV-based gene therapy products. Felipe is currently working as a Research Analytical Scientist in the collaborative project funded by Thermo Fisher Scientific, developing state-of-the-art LC-MS analytical methods to characterize oligonucleotide and viral vector-based gene therapy products.